Search research articles
Contact Us
Filters
Showing results (101-110 of 282) with videos related to
Page
of 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy
K C Marcus, L A Kalish, C N Coleman, et al.
JCO Oncology Practice
|
March 12, 2021
Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic
Kathryn Hawrot, Lawrence N Shulman, Ira J Bleiweiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer
K D Miller, J Picus, C Blanke, et al.
Journal of the American College of Surgeons
|
December 17, 2016
Reliability of the American College of Surgeons Commission on Cancer's Quality of Care Measures for Hospital and Surgeon Profiling
Jason B Liu, Kristopher M Huffman, Bryan E Palis, et al.
JCO Global Oncology
|
July 12, 2022
Nephroblastoma Treatment and Outcomes in a Low-Income Setting
Cyprien Shyirambere, Chandler Villaverde, Cam Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
January 5, 2002
Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies
C A Bunnell, J G Supko, J P Eder, et al.
Surgical Oncology
|
June 2, 2021
Risk factors for the presence of residual disease in women after partial mastectomy for invasive breast cancer: A single institution experience
Lauren M DeStefano, Lauren Coffua, Elise Wilson, et al.
Breast Cancer Research and Treatment
|
May 24, 2019
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Maria K Pomponio, Luke J Keele, Kevin R Fox, et al.
The Lancet. Oncology
|
August 20, 2021
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis
Zachary J Ward, Rifat Atun, Hedvig Hricak, et al.
Journal of Global Oncology
|
July 19, 2017
Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes
Neo Tapela, Ignace Nzayisenga, Roshan Sethi, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 282) with videos related to
Sort By:
Page
of 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy
K C Marcus, L A Kalish, C N Coleman, et al.
JCO Oncology Practice
|
March 12, 2021
Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic
Kathryn Hawrot, Lawrence N Shulman, Ira J Bleiweiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer
K D Miller, J Picus, C Blanke, et al.
Journal of the American College of Surgeons
|
December 17, 2016
Reliability of the American College of Surgeons Commission on Cancer's Quality of Care Measures for Hospital and Surgeon Profiling
Jason B Liu, Kristopher M Huffman, Bryan E Palis, et al.
JCO Global Oncology
|
July 12, 2022
Nephroblastoma Treatment and Outcomes in a Low-Income Setting
Cyprien Shyirambere, Chandler Villaverde, Cam Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
January 5, 2002
Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies
C A Bunnell, J G Supko, J P Eder, et al.
Surgical Oncology
|
June 2, 2021
Risk factors for the presence of residual disease in women after partial mastectomy for invasive breast cancer: A single institution experience
Lauren M DeStefano, Lauren Coffua, Elise Wilson, et al.
Breast Cancer Research and Treatment
|
May 24, 2019
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Maria K Pomponio, Luke J Keele, Kevin R Fox, et al.
The Lancet. Oncology
|
August 20, 2021
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis
Zachary J Ward, Rifat Atun, Hedvig Hricak, et al.
Journal of Global Oncology
|
July 19, 2017
Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes
Neo Tapela, Ignace Nzayisenga, Roshan Sethi, et al.
Page
of 29